Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites (Record no. 47591)

MARC details
000 -LEADER
fixed length control field 02264naaaa2200337uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/49994
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220219222045.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 978-2-88945-535-5
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9782889455355
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3389/978-2-88945-535-5
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lois A. Lampson
Relationship auth
245 10 - TITLE STATEMENT
Title Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Frontiers Media SA
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (95 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. Tumor immunotherapy has now shown its promise for many, its disappointments and failings for others. Going forward, brain tumor patients can both benefit and contribute. Tumor immunotherapy is steadily progressing. As experience accumulates, it is important to consider its generality. The reviews herein emphasize the brain’s place among other tumor sites. Two major topics are addressed. THE SITE: WHAT CAN WE EXPECT FROM IMMUNOTHERAPY WHEN THE TARGET IS IN THE BRAIN? Experience with immunotherapy for different targets in the brain, including tumor and also pathogens, is reviewed. Long-standing assumptions are confronted. The potential for beneficial responses is stressed. BRAIN TUMOR IMMUNOTHERAPY: WHAT HAVE WE LEARNED SO FAR? Clinical experience with brain tumor immunotherapy, from a variety of centers, is reviewed. Primary tumors, emphasizing glioblastoma, and brain metastases are each considered.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
Use and reproduction rights https://creativecommons.org/licenses/by/4.0/
Source of term cc
-- https://creativecommons.org/licenses/by/4.0/
546 ## - LANGUAGE NOTE
Language note English
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term blood-brain barrier
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term tumor antigen
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term brain immunology
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term glioblastoma
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term brain tumor immunotherapy
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term brain metastases
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term brain tumor
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term immune privilege
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://www.frontiersin.org/research-topics/2186/immunotherapy-for-tumor-in-the-brain-insights-from---and-for---other-tumor-sites">https://www.frontiersin.org/research-topics/2186/immunotherapy-for-tumor-in-the-brain-insights-from---and-for---other-tumor-sites</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/49994">https://directory.doabooks.org/handle/20.500.12854/49994</a>
Access status 0
Public note DOAB: description of the publication

No items available.